Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral nemonoxacin versus levofloxacin for community-acquired pneumonia has completed. The update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Nemonoxacin (Nemonoxacin)

Snippet

Sponsor: TaiGen Biotechnology Co., Ltd. | Conditions: Pneumonia | Phase 3 | Status: COMPLETED